1. Santra A, Chowdhury A, Ghatak S, Biswas A, Dhali GK. Arsenic induces apoptosis in mouse liver is mitochondria dependent and is abrogated by N-acetylcysteine. Toxicology and Applied Pharmacology. 2007;220(2):146-55.
2. Muthumani M, Prabu SM. Silibinin potentially protects arsenic-induced oxidative hepatic dysfunction in rats. Toxicology mechanisms and methods. 2012;22(4):277-88.
3. Jomova K, Jenisova Z, Feszterova M, Baros S, Liska J, Hudecova D, et al. Arsenic: toxicity, oxidative stress and human disease. Journal of Applied Toxicology. 2011;31(2):95-107.
4. Liu L, Trimarchi JR, Navarro P, Blasco MA, Keefe DL. Oxidative stress contributes to arsenic-induced telomere attrition, chromosome instability, and apoptosis. Journal of Biological Chemistry. 2003;278(34):31998-2004.
5. Bashir S, Sharma Y, Irshad M, Nag T, Tiwari M, Kabra M, et al. Arsenic induced apoptosis in rat liver following repeated 60 days exposure. Toxicology. 2006;217(1):63-70.
6. Majumdar S, Karmakar S, Maiti A, Choudhury M, Ghosh A, Das AS, et al. Arsenic-induced hepatic mitochondrial toxicity in rats and its amelioration by dietary phosphate. Environmental Toxicology and Pharmacology. 2011;31(1):107-18.
7. Rana T, Bera AK, Das S, Bhattacharya D, Pan D, Bandyopadhyay S, et al. Mushroom lectin protects arsenic induced apoptosis in hepatocytes of rodents. Human and Experimental Toxicology. 2011;30(4):307.
8. Horton A, Fairhurst S, Bus JSJCCRiT. Lipid peroxidation and mechanisms of toxicity. 1987;18(1):27-79.
9. Chiş I, Mureşan A, Oros A, Nagy A, Clichici SJAPH. Protective effects of Quercetin and chronic moderate exercise (training) against oxidative stress in the liver tissue of streptozotocin-induced diabetic rats. 2016;103(1):49-64.
10. Georis B, Cardenas A, Buchet JP, Lauwerys R. Inorganic arsenic methylation by rat tissue slices. Toxicology. 1990;63(1):73-84.
11. Buchet JP, Lauwerys R. Role of thiols in the in-vitro methylation of inorganic arsenic by rat liver cytosol. Biochemical Pharmacology. 1988;37(16):3149-53.
12. Gyurasics Á, Varga F, Gregus Z. Glutathione-dependent biliary excretion of arsenic. Biochemical Pharmacology. 1991;42(3):465-8.

13. Muthumani M, Prabu SM. Arsenic Induced Oxidative Stress and Its Possible Reversal by Chelation Therapy. Research & Reviews: A Journal of Toxicology. 2019;2(2):16-37.
14. Itokawa H, Shi Q, Akiyama T, Morris-Natschke SL, Lee K-H. Recent advances in the investigation of curcuminoids. Chinese Medicine. 2008;3:11.
15. Yadav A, Lomash V, Samim M, Flora SJS. Curcumin encapsulated in chitosan nanoparticles: A novel strategy for the treatment of arsenic toxicity. Chemico-Biological Interactions. 2012;199(1):49-61.
16. Mathews VV, Binu P, Sauganth Paul MV, Abhilash M, Manju A, Nair RH. Hepatoprotective efficacy of curcumin against arsenic trioxide toxicity. Asian Pacific Journal of Tropical Biomedicine. 2012;2(2, Supplement):S706-S11.
17. Dadban Shahamat M, Dabidi Roshan V, Farazmandfar T. Effect of Continuous Aerobic Exercise on Bax/Bcl-2 Ratio and Doxorubicin-induced Liver Toxicity in Aging model Rats. Journal of Mazandaran University of Medical Sciences. 2018;28(165):36-46.
18. Sadat-Hoseini SK, Dabidi Roshan V. Is sub-chronic exercise in Combination with medicinal nanoparticles a protective strategy against Doxorubicin-induced Hepatic oxidative stress and apoptosis in aging model rats? Nanomedicine Journal. 2017;4(4):224-31.
19. Hinkley JM, Morton AB, Ichinoseki-Sekine N, Huertas AM, Smuder AJ. Exercise Training Prevents Doxorubicin-induced Mitochondrial Dysfunction of the Liver. Medicine and science in sports and exercise. 2019;51(6):1106-15.
20. Jiang H-K, Wang Y-H, Sun L, He X, Zhao M, Feng Z-H, et al. Aerobic interval training attenuates mitochondrial dysfunction in rats post-myocardial infarction: roles of mitochondrial network dynamics. International journal of molecular sciences. 2014;15(4):5304-22.
21. Abdul KSM, Jayasinghe SS, Chandana EP, Jayasumana C, De Silva PMC. Arsenic and human health effects: A review. Environmental toxicology and pharmacology. 2015;40(3):828-46.
22. Ferrario D, Gribaldo L, Hartung T. Arsenic exposure and immunotoxicity: a review including the possible influence of age and sex. Current environmental health reports. 2016;3(1):1-12.
23. Habib M, Bhatti S, ur Rehman S, Javed N, Shahbaz Aslam M, Shahzad N, et al. Hepatoprotective role of swimming against arsenic induced oxidative stress in mice. Journal of King Saud University - Science. 2019.
24. Bai J, Yao X, Jiang L, Zhang Q, Guan H, Liu S, et al. Taurine protects against As2O3-induced autophagy in livers of rat offsprings through PPARgamma pathway. Scientific reports. 2016;6:27733.
25. Eguchi A, Wree A, Feldstein AE. Biomarkers of liver cell death. Journal of Hepatology. 2014;60(5):1063-74.
26. Schutte B, Henfling M, Kölgen W, Bouman M, Meex S, Leers MP, et al. Keratin 8/18 breakdown and reorganization during apoptosis. Experimental cell research. 2004;297(1):11-26.
27. Ku N-O, Liao J, Omary MB. Apoptosis generates stable fragments of human type I keratins. Journal of Biological Chemistry. 1997;272(52):33197-203.
28. Hemmati AA, Olapour S, Varzi HN, Khodayar MJ, Dianat M, Mohammadian B, et al. Ellagic acid protects against arsenic trioxide–induced cardiotoxicity in rat. Human & Experimental Toxicology. 2017;37(4):412-9.
29. Biswas J, Roy S, Mukherjee S, Sinha D, Roy MJAPjocpA. Indian spice curcumin may be an effective strategy to combat the genotoxicity of arsenic in Swiss albino mice. 2010;11(1):239.
30. Hoydal M, Wisloff U, Kemi O, Ellindsen O. Running speed and maximal oxygen uptake in rats and mice: practical omplications for exercise training. European Journal of Crdiovascular Prevention and Rehabilitation 2077;14(6):753-60.
31. Waring CD, Vicinanza C, Papalamprou A, Smith AJ, Purushothaman S, Goldspink DF, et al. The adult heart responds to increased workload with physiologic hypertrophy, cardiac stem cell activation, and new myocyte formation. European heart journal. 2012;35(39):2722-31.
32. Kraljevic J, Marinovic J, Pravdic D, Zubin P, Dujic Z, Wisloff U, et al. Aerobic interval training attenuates remodelling and mitochondrial dysfunction in the post-infarction failing rat heart. Cardiovascular research. 2013;99(1):55-64.
33. Hafstad AD, Lund J, Hadler-Olsen E, Höper AC, Larsen TS, Aasum E. High-and moderate-intensity training normalizes ventricular function and mechanoenergetics in mice with diet-induced obesity. Diabetes. 2013;62(7):2287-94.
34. Kramer G, Erdal H, Mertens HJMM, Nap M, Mauermann J, Steiner G, et al. Differentiation between Cell Death Modes Using Measurements of Different Soluble Forms of Extracellular Cytokeratin 18. Cancer Research. 2004;64(5):1751.
35. Al-Rubaei Z, Mohammad TU, Ali LK. Effects of local curcumin on oxidative stress and total antioxidant capacity in vivo study. Pak J Biol Sci. 2014;17(12):1237-41.
36. Kotyzová D, Bludovská M, Eybl VJEt, pharmacology. Differential influences of various arsenic compounds on antioxidant defense system in liver and kidney of rats. 2013;36(3):1015-21.
37. Saha BJ, Pharmacology BJo. Effect of ascorbic acid on reduced glutathione level in arsenic-loaded isolated liver tissues of rat. 2006;1(2):68-71.
38. Ranjbar A, Gholami L, Ghasemi H, Kheiripour NJNJ. EEffects of nano-curcumin and curcumin on the oxidant and antioxidant system of the liver mitochondria in aluminum phosphide-induced experimental toxicity. 2020;7(1):58-64.
39. Ashrafizadeh M, Ahmadi Z, Mohammadinejad R, Farkhondeh T, Samarghandian SJCMM. Curcumin activates the Nrf2 pathway and induces cellular protection against oxidative injury. 2020;20(2):116-33.
40. Delwing-de Lima D, Ulbricht ASSF, Werlang-Coelho C, Delwing-Dal Magro D, Joaquim VHA, Salamaia EM, et al. Effects of two aerobic exercise training protocols on parameters of oxidative stress in the blood and liver of obese rats. The Journal of Physiological Sciences. 2018;68(5):699-706.
41. Gaucher C, Boudier A, Bonetti J, Clarot I, Leroy P, Parent M. Glutathione: Antioxidant Properties Dedicated to Nanotechnologies. Antioxidants (Basel). 2018;7(5):62.
42. Simioni C, Zauli G, Martelli AM, Vitale M, Sacchetti G, Gonelli A, et al. Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging. 2018;9(24):17181.
43. Akter J, Hossain MA, Takara K, Islam MZ, Hou D-XJCB, Toxicology PPC, et al. Antioxidant activity of different species and varieties of turmeric (Curcuma spp): Isolation of active compounds. 2019;215:9-17.
44. Binu P, Priya N, Abhilash S, Vineetha RC, Nair RH. Studies on curative efficacy of monoterpene eugenol on anti- leukemic drug arsenic trioxide induced cardiotoxicity. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2017;91:559-66.
45. Sun TL, Liu Z, Qi ZJ, Huang YP, Gao XQ, Zhang YY. (-)-Epigallocatechin-3-gallate (EGCG) attenuates arsenic-induced cardiotoxicity in rats. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2016;93:102-10.
46. Hirata M, Tanaka A, Hisanaga A, Ishinishi N. Effects of glutathione depletion on the acute nephrotoxic potential of arsenite and on arsenic metabolism in hamsters. Toxicology and Applied Pharmacology. 1990;106(3):469-81.
47. Ramos O, Carrizales L, Yáñez L, Mejía J, Batres L, Ortíz D, et al. Arsenic increased lipid peroxidation in rat tissues by a mechanism independent of glutathione levels. 1995;103(suppl 1):85-8.
48. Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology (Baltimore, Md). 2006;44(1):27-33.
49. Abraham MC, Shaham S. Death without caspases, caspases without death. Trends in cell biology. 2004;14(4):184-93.
50. Bernstein DE. NASH and NAFLD. Clinics in Liver Disease. 2018;22(1):i.
51. Kanda T, Matsuoka S, Yamazaki M, Shibata T, Nirei K, Takahashi H, et al. Apoptosis and non-alcoholic fatty liver diseases. World J Gastroenterol. 2018;24(25):2661-72.
52. Choudhury S, Ghosh S, Mukherjee S, Gupta P, Bhattacharya S, Adhikary A, et al. Pomegranate protects against arsenic-induced p53-dependent ROS-mediated inflammation and apoptosis in liver cells. The Journal of Nutritional Biochemistry. 2016;38:25-40.
53. Rivas-Santiago C, González-Curiel I, Zarazua S, Murgu M, Ruiz Cardona A, Lazalde B, et al. Lipid Metabolism Alterations in a Rat Model of Chronic and Intergenerational Exposure to Arsenic. BioMed Research International. 2019;2019:4978018.
54. Joka D, Wahl K, Moeller S, Schlue J, Vaske B, Bahr MJ, et al. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis. 2012;55(2):455-64.
55. Mehta M, Hundal S. Biochemical and histological alterations in liver following sub chronic exposure of arsenic. 2015.
56. Ullah F, Liang A, Rangel A, Gyengesi E, Niedermayer G, Münch G. High bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation. Archives of Toxicology. 2017;91(4):1623-34.
57. Agrawal SS, Gullaiya S, Dubey V, Singh V, Kumar A, Nagar A, et al. Neurodegenerative Shielding by Curcumin and Its Derivatives on Brain Lesions Induced by 6-OHDA Model of Parkinson's Disease in Albino Wistar Rats. Cardiovascular Psychiatry and Neurology. 2012;2012:1-8.
58. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta medica. 1998;64(04):353-6.
59. Garland M, Morris JS, Colditz GA, Stampfer MJ, Spate VL, Baskett CK, et al. Toenail Trace Element Levels and Breast Cancer: A Prospective Study. American Journal of Epidemiology. 1996;144(7):653-60.

60.          Islam MS, Mohanto NC, Karim MR, Aktar S, Hoque MM, Rahman A, et al. Elevated concentrations of serum matrix metalloproteinase-2 and-9 and their associations with circulating markers of cardiovascular diseases in chronic arsenic-exposed individuals. Environmental Health. 2015;14(1):92.